Patent · US Active

Compounds and methods for CD73 modulation and indications therefor

US11807626B2 · kind B2 · utility

1Cited by

89References

40Claims

0Family size

Assignee

OPNA BIO SA · CH

Inventors

Songyuan Shi · Fremont, US
John Buell · San Francisco, US
Zuojun Guo · Pasadena, US
Cuong Ly · Burlingame, US
Wayne Spevak · Berkeley, US
Mark Vander Wal · Berkeley, US
Jack Walleshauser · Berkeley, US
Chao Zhang · 安丰镇, CN
Jiazhong Zhang · Foster City, US

Key dates

Filing date	Apr 22, 2021
Grant date	Nov 7, 2023
Priority date	—
Expiry date	Oct 1, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/107
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds of Formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.